|
||||||||
What do you want to do?
|
|||||||
BCCA Statement on COVID vaccination for 5 to 17-year-olds – 31 December 2021
Covid–19 Vaccination for children and young people On 22
December 2021, in response to the current wave of Omicron infection, the JCVI
updated and extended its advice on primary Covid-19 vaccination for 5 to
11-year-olds in high-risk groups, booster vaccination for 12 to 15-year-olds in
high-risk groups and booster vaccination for 16 to 17-year-olds (JCVI Covid-19 vaccination advice for children and young
people). The Green
Book recommendations have been updated (Green Book information on vaccines 24 Dec 21). Considerations With
regard the primary vaccination of 5 to 11-year-olds, the JCVI has considered
the potential benefits and risks of vaccination to the children themselves.
These are finely balanced largely because the risks associated with Covid-19
infection are very low in this age group. The JCVI considered data on: ·
Risk of
hospitalisation, paediatric intensive care unit (PICU) admission, mortality and
paediatric inflammatory multisystem syndrome temporally associated with
SARS-CoV-2 (PIMS-TS) following Covid-19 infection ·
Effectiveness of
Covid-19 vaccination in preventing infection, symptomatic disease,
hospitalisation, intensive care admission and mortality, and the prevention of PIMS-TS and ‘long COVID’ ·
Incidence and
severity of suspected adverse events following vaccination including available
data on the risk of myocarditis following vaccination ·
Estimates of the
proportion of 5 to 11-year-olds with prior Covid-19 infection in the UK ·
Risk-benefit
analysis undertaken by the UK Health Security Agency (UKHSA) Summary
of latest JCVI advice Young adults
(16-17 years) All
16 to
17-year-olds should now be offered a booster vaccination 3 months after
completion of their primary course (unless contraindicated). Children
(12-15 years) 12 to 15-year-olds who are: ·
In a recognised higher risk group (which includes haemodynamically
significant congenital and acquired heart disease, or less severe heart disease
with other co-morbidity- see Table 4 in Green Book information on vaccines 24 Dec 21)
or ·
A household contact of someone who is immunosuppressed should be offered a booster vaccination 3 months
after completion of their primary course. Boosters in children aged 12 to
15 years who are not at high risk will be reviewed by the JCVI in due course. Children (5-11
years) 5 to 11-year-olds who are: ·
In a recognised higher risk group (which includes haemodynamically
significant congenital and acquired heart disease, or less severe heart disease
with other co-morbidity- see Table 4 in Green Book information on vaccines 24 Dec 21)
or ·
A household contact of someone who is immunosuppressed should be offered two 10
micrograms doses of the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) with an
interval of 8 weeks between the first and second doses.
These haemodynamically significant congenital and acquired
heart disease categories in children have been previously considered and published by the
BCCA (14/09/21). Other children aged 5-11 years A decision on the vaccination of
children aged 5 to 11 years who are not in recognised risk groups is pending
further consideration by JCVI. Boosters in children aged 5-11 years will
be reviewed in due course. COVID vaccination after COVID-19 infection and PIMS-TS Advice unchanged. See further detail in BCCA
statement 13 Dec 21 and Green
Book information on vaccines 24 Dec 21 Page 31 COVID-19 vaccination and cardiac surgery There
is no specific data to guide time interval between COVID-19 vaccination and
surgery and vice-versa. The
Royal College of Surgeons (Eng) (RCS
(Eng) guidance) states that: ·
Essential urgent surgery should take place, irrespective of vaccination
status. ·
Non-urgent elective surgery can also take place soon after vaccination.
There is some rationale for separating the date of surgery from vaccination by
a few days (at most 1 week) so that any symptoms such as fever might be
correctly attributed to the consequences of either vaccination or the operation
itself. BCCA
|
||
|
|
||